Recent

• A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial
• Elon Musk Excites Psychedelic Industry CEOs with This Tweet
• 5 Most Important Psychedelic Clinical Trials in 2022
• Ketamine Trial for Alcohol Use Disorder Delivers Very Promising Results
• Psychedelic Business Spotlight — January 7
• Psychedelic Business Spotlight: November 19
• Psychedelic Business Spotlight: October 29
• Psychedelic Business Spotlight: September 17, 2021
• Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat Addiction
• U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction